SCHEMBL382671

SCHEMBL382671

CC(C)(C)N(C(=O)O)C(C[N+](=O)[O-])c1ccccc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.44
CNR2 P34972 2/20 0.39
ACP3 P15309 1/20 0.36
CPA1 P15085 3/20 0.35
POLQ O75417 1/20 0.34
CYP3A4 P08684 2/20 0.34
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34
CACNA2D1 P54289 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNB1 Q02641 1/20 0.34
CACNA1C Q13936 1/20 0.34
ESR1 P03372 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL382428 0.83 ACP3 (0.43) CNR2ACP3POLQCYP3A4ALDH1A1
SCHEMBL382108 0.82 ALDH1A1 (0.41) CNR1CPA1CYP3A4ALDH1A1
SCHEMBL167206 0.82 CNR2 (0.42) CNR2ACP3POLQCYP3A4ALDH1A1
SCHEMBL380984 0.81 CNR2 (0.41) CNR2ACP3POLQCYP3A4ALDH1A1
SCHEMBL19244866 0.81 CNR2 (0.41) CNR2ACP3POLQCYP3A4ALDH1A1
SCHEMBL19244827 0.81 CNR2 (0.39) CNR2ACP3POLQCYP3A4ALDH1A1
SCHEMBL19244870 0.79 CNR2 (0.40) CNR2ACP3POLQCYP3A4ALDH1A1
SCHEMBL16674049 0.78 MEN1 (0.37) CNR1CPA1CYP3A4ALDH1A1CYP1A2
SCHEMBL382042 0.76 CNR2 (0.40) CNR2ACP3CYP3A4ALDH1A1POLB
SCHEMBL381588 0.76 CNR1 (0.45) CNR1ACP3CYP3A4ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2408751-B1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof BAYER IP GMBH (DE) 2017-08-23 EP disclosed
EP-2408751-A1 Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof Bayer Pharma Aktiengesellschaft (DE) 2012-01-25 EP disclosed
WO-2010105770-A1 SUBSTITUTED 2-ACETAMIDO-5-ARYL-1,2,4-TRIAZOLONES AND USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-09-23 WO disclosed